Tag: heart disease

The study arrives at a critical juncture for public health in the United States, where the prevalence of metabolic diseases has reached epidemic proportions. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 40.1 million Americans are currently living with diabetes, representing more than 12% of the total population. The chronic nature…

A comprehensive retrospective cohort study has established a definitive link between mild levels of maternal glucose intolerance during pregnancy and an increased risk of obesity in children as they transition into adolescence. The research, published in the peer-reviewed Journal of Clinical Endocrinology & Metabolism, indicates that even minor deviations in blood sugar levels—levels that may…

The clinical landscape for obesity management is undergoing a profound transformation, shifting from a traditional focus on caloric restriction and willpower toward a comprehensive, biological understanding of the condition as a chronic disease. Dr. Zeb I. Saeed, MD, a prominent member of the steering committee for the Endocrine Society’s Early Career Special Interest Group (SIG),…

The Pershing Square Foundation has officially announced that Dr. Daniel Hochbaum, a distinguished member of the Endocrine Society and an assistant professor at Harvard Medical School, is among the select recipients of the 2026 "MIND" (Maximizing Innovation in Neurodegenerative Diseases) Prize. This prestigious accolade includes a $750,000 grant, distributed over a three-year period, designed to…

The medical landscape for treating obesity and metabolic dysfunction is undergoing a seismic shift, transitioning from a reactive model centered on managing complications to a proactive approach targeting the underlying pathophysiology of excess adiposity. At the recent virtual Science Writers Conference hosted by the Endocrine Society, leading experts gathered to dissect the rapid advancements in…

The Endocrine Society has officially named five distinguished scientists as the winners of the 2026 Early Investigator Awards, a prestigious honor designed to cultivate the next generation of leadership in the field of endocrinology. These awards, which serve as a cornerstone of the Society’s commitment to scientific advancement, recognize the extraordinary contributions and potential of…

The Endocrine Society, the world’s oldest and largest organization of scientists and clinicians dedicated to hormone research and the clinical care of patients with endocrine conditions, has officially announced its endorsement of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. This bipartisan legislative effort, introduced by a coalition of United States…

The clinical landscape for metabolic health underwent a significant transformation in late 2025 as new data emerged regarding the cardiovascular impacts of glucagon-like peptide-1 receptor agonists (GLP-1RAs). Once viewed primarily through the lens of glycemic control and, more recently, as potent tools for weight loss, these agents are now being scrutinized for their ability to…

The integration of obesity recognition into routine clinical practice has taken a significant step forward with the introduction of a new validated process measure designed to identify patients who meet body mass index (BMI) criteria for obesity but remain undiagnosed within electronic health records (EHR). Published in the Journal of Clinical Endocrinology & Metabolism (JCEM),…

The pervasive presence of synthetic "forever chemicals" in the environment has long been a subject of intense scientific scrutiny, but new longitudinal research published in the Journal of the Endocrine Society suggests that the health impacts of these substances may be deeply rooted in the early stages of human development. Specifically, the study indicates that…